Lyssikatos Joseph P 4
4 · Enliven Therapeutics, Inc. · Filed Sep 25, 2025
Insider Transaction Report
Form 4
Lyssikatos Joseph P
CHIEF SCIENTIFIC OFFICER
Transactions
- Sale
Common Stock
2025-09-23$20.03/sh−1,500$30,045→ 931,688 total(indirect: See footnote)
Footnotes (2)
- [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 15, 2024.
- [F2]The shares are held by The Lyssikatos Revocable Trust 12/15/2011 for which the Reporting Person serves as trustee.